Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)
Clinical trial NCT04383574 · COMPLETED
Trial details
- NCT number
- NCT04383574
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2021-12-28
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.